-
Emerging regional markets show promise as CDMO globalisation trend grows
cphi-online
September 08, 2021
This is the consensus view of experts in the biopharmaceutical outsourcing sector who say the pace of growth is showing no signs of slowing down.
-
Recipharm expands its analytical services offering in India
cphi-online
August 26, 2021
The CDMO inaugurates its new analytical laboratory under Recipharm Analytical Solutions
-
Curia lays out plans to expand complex API manufacturing capacity
cphi-online
August 23, 2021
The $35 million investment will more than double the site’s batch-size scaling and product output.
-
Cell and gene therapy manufacturing services market to value $13.8 billion by 2026
europeanpharmaceuticalreview
August 12, 2021
The global cell and gene therapy manufacturing services market is expected to grow at a CAGR of 12.4 percent in the next five years.
-
Recro eyes expansion to full-service CDMO status
cphi-online
August 12, 2021
The solid oral dose specialist signs letter of intent for acquisition of a CDMO providing a full range of services
-
TriRx Completes Acquisition of Elanco Animal Health Facility
contractpharma
August 09, 2021
Site in Shawnee, KS to become a global center of excellence serving the pharmaceutical contract development and manufacturing market.
-
GRAM Expands Footprint with New Finishing Center
contractpharma
August 09, 2021
New 110,000 sq.-ft. finishing center is the injectable CDMO's fourth GMP manufacturing facility.
-
Global API CDMO market to value almost $140bn by 2028
europeanpharmaceuticalreview
August 06, 2021
Market research suggests the Asia Pacific region could soon overtake Europe and North America in the active pharmaceutical ingredient (API) contract development and manufacturing organisation (CDMO) market.
-
Tech transfer: a many-layered artform that demands precision and communication
cphi-online
August 04, 2021
Tech transfer is a crucial phase that converts clinical promise into commercial gain but pressure on sponsors to reduce time to market in the age of COVID-19 means CDMOs have to be on top of their game to deliver.
-
Global Cell & Gene Therapy Mfg. Market Could Reach $57.4B by 2028
contractpharma
August 02, 2021
Market estimated to grow at CAGR of 20% from 2021 to 2028 due to an exponential rise in clinical pipeline along with rising number of regulatory approvals.